The expression of TMED2 was increased in ovarian mucinous adenocarcinoma, ovarian serous adenocarcinoma and ovarian endometrioid adenocarcinoma was elevated compared to normal ovarian tissues(Figure 1A(III-V); P=0.043, 0.016 and 0.049 respectively). Here, TMED2 is linked to ovarian endometrioid adenocarcinoma.